Viewing Study NCT04876092


Ignite Creation Date: 2025-12-24 @ 3:52 PM
Ignite Modification Date: 2025-12-27 @ 6:34 AM
Study NCT ID: NCT04876092
Status: COMPLETED
Last Update Posted: 2025-08-21
First Post: 2021-05-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in Combination in B-cell NHL and CLL
Sponsor: Janssen Research & Development, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module